GE HealthCare (GEHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended March 2025, GE HealthCare Technologies (GEHC) reported revenue of $4.78 billion, up 2.7% over the same period last year. EPS came in at $1.01, compared to $0.90 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $4.66 billion, representing a surprise of +2.57%. The company delivered an EPS surprise of +10.99%, with the consensus EPS estimate being $0.91.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how GE HealthCare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Imaging: $2.14 billion versus $2.03 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -13.2% change. Revenues- Other: $13 million versus $13.30 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -13.3% change. Revenues- PDx: $632 million versus $631.52 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +5.5% change. Revenues- PCS: $753 million versus the four-analyst average estimate of $749.38 million. The reported number represents a year-over-year change of +0.8%. View all Key Company Metrics for GE HealthCare here>>>Shares of GE HealthCare have returned -14.4% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GE HealthCare Technologies Inc. (GEHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks